NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index.
The underlying index was composed of common stocks ofU. S. biotechnology and genome companies.
These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 5.94% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 5.27% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 5.17% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 5.09% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 4.95% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 4.85% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 4.78% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 4.64% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.56% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.40% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.66% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 3.59% |
| BCRX | BioCryst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.59% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 3.46% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 3.38% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 3.33% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.13% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.05% |
| VCEL | Vericel Corp Ord | Healthcare | Biotechnology | 3.02% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.02% |